作者:
Beatriz,Castro-Robles [1]
;
Francisco J,Cimas [2]
;
Lourdes,Arias-Salazar [1]
;
Jesús,Ontañón [3]
;
Julia,Lozano [4]
;
Susana,López-López [1]
;
Fernando,Andrés-Pretel [5]
;
María Ángeles,Requena-Calleja [6]
;
Antonio,Mas [7]
;
Gemma,Serrano-Heras [1]
;
Tomás,Segura [8]
;
Javier,Solera [9]
作者单位:
Research Unit, General University Hospital of Albacete, Health Service of Castilla-La Mancha (SESCAM), Albacete, Spain.
[1]
Molecular Oncology Laboratory, Molecular Medicine Unit, Associated Unit of Biomedicine, University of Castilla-La Mancha-Spanish National Research Council (UCLM-CSIC), Albacete, Spain.;Mecenazgo COVID-19, Faculty of Medicine, University of Castilla-La Mancha, Albacete, Spain.
[2]
Immunology Unit, Clinical Analysis Department, General University Hospital of Albacete, Albacete, Spain.
[3]
Microbiology Department, General University Hospital of Albacete, Albacete, Spain.
[4]
Research Unit, General University Hospital of Albacete, Department of Statistics, Foundation of the National Paraplegics Hospital of Toledo, Albacete, Spain.
[5]
Internal Medicine Department, General University Hospital of Albacete, Albacete, Spain.
[6]
Biomedicine Institute of UCLM (IB-UCLM), Faculty of Medicine, University of Castilla-La Mancha, Albacete, Spain.;Faculty of Pharmacy, University of Castilla-La Mancha, Albacete, Spain.;Associated Unit of Biomedicine UCLM-CSIC, University of Castilla-La Mancha, Ciudad Real, Spain.
[7]
Biomedicine Institute of UCLM (IB-UCLM), Faculty of Medicine, University of Castilla-La Mancha, Albacete, Spain.;Neurology Department, General University Hospital of Albacete, SESCAM, Albacete, Spain.
[8]
Faculty of Medicine, University of Castilla-La Mancha, Albacete, Spain.
[9]
DOI
10.3389/fimmu.2024.1471401
PMID
39835131
发布时间
2025-01-22